Abstract
Oxidative stress has been found to play important role in several neuropsychiatric diseases including Obsessive Compulsive Disorder. A longitudinal case control study was conducted to evaluate the oxidative stress in 30 newly diagnosed obsessive compulsive disorder patients and same number of control patients. Serum thiobarbituric acid reacting substances, plasma ascorbate were assessed to evaluate oxidative stress and Yale Brown obsessive compulsive scale for disease severity before and after treatment with Fluoxetine at the average dosage of 40 mg/day. Improvement in Yale Brown obsessive compulsive scale score by about 43% after 12 weeks treatment was associated with significantly decreased thiobarbituric acid reacting substances and increased plasma ascorbate values (p < 0.05). The newly diagnosed obsessive compulsive disorder patients had higher serum thiobarbituric acid reacting substances as well as a lower plasma ascorbate levels than the control population. Thus, the present study suggested a significant role of oxidative stress in obsessive compulsive disorder and showed that a successful treatment with Fluoxetine not only improves the clinical scenario but also reduces the oxidative stress that may further improve the prognosis of the disease.
Key Words: Oxidative stress, Obsessive Compulsive Disorder, Thiobarbituric acid reacting substances, Ascorbate, Fluoxetine
Full Text
The Full Text of this article is available as a PDF (51.2 KB).
References
- 1.Lancu L., Dannon P.N., Zohar J. Obsessive-compulsive disorder. In: Gelder M.G., Lopez Ibor J.J., Andreasen, editors. New Oxford Textbook of Psychiatry. New York, US: Oxford University Press Inc; 2005. p. 823. [Google Scholar]
- 2.Robins L.N., Helzer J.E., Weissman M.M., Orvaschel H., Gruenberg E., Burke J.D., Jr, Regier D.A. Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psych. 1984;41:949–958. doi: 10.1001/archpsyc.1984.01790210031005. [DOI] [PubMed] [Google Scholar]
- 3.Karno M., Golding J.M., Sorenson S.B., Burnam M.A. The epidemiology of obsessive compulsive disorder in five US communities. Arch Gen Psych. 1988;45:1094–1099. doi: 10.1001/archpsyc.1988.01800360042006. [DOI] [PubMed] [Google Scholar]
- 4.Bilici M., Efe H., Koroglu M.A., Uydu H.A., Bekaroglu M., Deger O. Antioxidative enzyme activities and lipid peroxidation in major depression: Alteration by antidepressant treatment. J Affect Disord. 2001;64:43–51. doi: 10.1016/S0165-0327(00)00199-3. [DOI] [PubMed] [Google Scholar]
- 5.Dadheech G., Mishra S., Gautam S., Sharma P. Evaluation of antioxidant deficit in schizophrenia. Ind J Psych. 2008;50:16–20. doi: 10.4103/0019-5545.39753. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Mahadik S.P., Evans D.R. Is Schizophrenia a metabolic brain disorder? Membrane phospholipid dysregulation and its therapeutic implication. Psychiatric Clinics of North America. 2003;26:93. doi: 10.1016/S0193-953X(02)00033-3. [DOI] [PubMed] [Google Scholar]
- 7.Jesberger J.A. Oxygen free radical and brain function. Int J Neurosci. 1991;57:1–17. doi: 10.3109/00207459109150342. [DOI] [PubMed] [Google Scholar]
- 8.Weber G.F. The pathophysiology of reactive oxygen intermediates in the central nervous system. Med Hypothesis. 1994;43:223–230. doi: 10.1016/0306-9877(94)90070-1. [DOI] [PubMed] [Google Scholar]
- 9.Ersan S., Bakir E., Ersan E.E., Dogan O. Examination of free radical metabolism and antioxidant defence system elements in patients with obsessive compulsive disorder. Progress in Neuro-Psychopharmacol Biol Psychiatry. 2006;30:1039–1042. doi: 10.1016/j.pnpbp.2006.03.034. [DOI] [PubMed] [Google Scholar]
- 10.Lohr J.B. Oxygen radicals and neuropsychiatric illness. Some speculations. Arch Gen Psych. 1991;48:1097–1106. doi: 10.1001/archpsyc.1991.01810360061009. [DOI] [PubMed] [Google Scholar]
- 11.Pigott T.A., Seay S.M. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive compulsive disorder. J Clin Psych. 1999;60:101–106. doi: 10.4088/jcp.v60n0206. [DOI] [PubMed] [Google Scholar]
- 12.Goodman W.K., Price L.H., Rasmussen S.A., et al. The Yale-Brown Obsessive Compulsive Scale. Arch Gen Psych. 1989;46:1006–1016. doi: 10.1001/archpsyc.1989.01810110048007. [DOI] [PubMed] [Google Scholar]
- 13.Dakhale GN, Khanzode SD, Khanzode SS, Saoji A. Supplementation of vitamin C with atypical antipsychotics reduces oxidative stress and improves the outcome of schizophrenia. Psychopharmacol (Berl) 2005; 182(4): Epub Oct 19. [DOI] [PubMed]
- 14.Dahle L.K., Hill E.G., Holman R.T. The thiobarbituric acid reaction and the auto oxidation of polyunsaturated fatty acid methyl esters. Arch Biochem Biophys. 1962;98:253–261. doi: 10.1016/0003-9861(62)90181-9. [DOI] [PubMed] [Google Scholar]
- 15.McCormick DB, Greene HL. Vitamins. In: Burtis CA, Ashwood ER, editors. Tietz Textbook of Clinical Chemistry. 3rd edition, W.B. Saunders Company Philadelphia 1999: pp 1025.
- 16.Koran L.M. Obsessive-Compulsive and related disorders in adults-A comprehensive clinical guide. Delhi: Cambridge University Press, First South Asian edition, Replica press Pvt Ltd; 2000. pp. 48–49. [Google Scholar]
- 17.Koluglu M., Atmaca M., Tezcan E., Gecici O., Tunckol H., Ustundag B. Antioxidant Enzyme Activities and Malondialdehyde Levels in Patients with Obsessive-Compulsive Disorder. Neuropsychobiol. 2002;46:27–32. doi: 10.1159/000063573. [DOI] [PubMed] [Google Scholar]
- 18.Dadheech G., Mishra S., Gautam S., Sharma P. Oxidative stress and ascorbic acid status in schizophrenics. SFRR-Indian Bull. 2005;4:23–25. doi: 10.1007/BF02912908. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Dadheech G., Mishra S., Gautam S., Sharma P. Oxidative stress, α-tocopherol, ascorbic acid and reduced glutathione status in schizophrenics. Ind J Clin Biochem. 2006;21:34–38. doi: 10.1007/BF02912908. [DOI] [PMC free article] [PubMed] [Google Scholar]